Linezolid plasma concentrations and occurrence of drug-related haematological toxicity in patients with Gram-positive infections

International Journal of Antimicrobial Agents

Volumn 41, Issue 6, 2013, Pages 586-589

  Cattaneo, Dario ^a   Orlando, Giovanna ^a   Cozzi, Valeria ^a   Cordier, Laura ^a   Baldelli, Sara ^a   Merli, Stefania ^a   Fucile, Serena ^a   Gulisano, Cecilia ^a   Rizzardini, Giuliano ^a   Clementi, Emilio ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b SCIENTIFIC INSTITUTE   (Italy)

Author keywords

Gram positive infections; Haematological toxicity; Linezolid; Therapeutic drug monitoring

Indexed keywords

CREATININE; LINEZOLID; RIFAMPICIN;

ADULT; AGE DISTRIBUTION; ANEMIA; ARTICLE; BLOOD TOXICITY; BONE INFECTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DISTRIBUTION; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESISTANT TUBERCULOSIS; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; GRAM POSITIVE INFECTION; HUMAN; INFECTIOUS ARTHRITIS; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PANCYTOPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ACETAMIDES; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BLOOD CELLS; DRUG MONITORING; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; OXAZOLIDINONES; PLASMA; PROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 84877705625     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.02.020     Document Type: Article

References (15)

1. S. Ager, and K. Gould Clinical update on linezolid in the treatment of Gram-positive bacterial infections Infect Drug Resist 5 2012 87 102
2. H. Cox, and N. Ford Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis Int J Tuberc Lung Dis 16 2012 447 454
3. G. French Safety and tolerability of linezolid J Antimicrob Chemother 51 Suppl. 2 2003 ii45 ii53
4. Y. Tsuji, Y. Hiraki, A. Mizoguchi, W. Hayashi, R. Kamohara, and H. Kamimura Pharmacokinetics of repeated dosing of linezolid in a hemodialysis patient with chronic renal failure J Infect Chemother 14 2008 156 160
5. K. Matsumoto, A. Takeshita, K. Ikawa, A. Shigemi, K. Yaji, and Y. Shimodozono Higher linezolid exposure and higher frequency of thrombocytopenia in patients with renal dysfunction Int J Antimicrob Agents 36 2010 179 181
6. T. Sasaki, H. Takane, K. Ogawa, S. Isagawa, T. Hirota, and S. Higuchi Population pharmacokinetic and pharmacodynamic analysis of linezolid and a hematologic side effect, thrombocytopenia, in Japanese patients Antimicrob Agents Chemother 55 2011 1867 1873
7. H. Dong, X. Wang, Y. Dong, J. Lei, H. Li, and H. You Clinical pharmacokinetic/pharmacodynamic profile of linezolid in severely ill intensive care unit patients Int J Antimicrob Agents 38 2011 296 300
8. F. Pea, P. Viale, P. Cojutti, B. Del Pin, E. Zamparini, and M. Furlanut Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients J Antimicrob Chemother 67 2012 2034 2042
9. F. Pea, M. Furlanut, P. Cojutti, F. Cristini, E. Zamparini, and L. Franceschi Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis Antimicrob Agents Chemother 54 2010 4605 4610
10. D. Cattaneo, S. Baldelli, F. Conti, V. Cozzi, and E. Clementi Determination of linezolid in human plasma by high-performance liquid chromatography with ultraviolet detection Ther Drug Monit 32 2010 520 524
11. K.S. Estes, and H. Derendorf Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin Eur J Med Res 15 2010 533 543
12. N. Plock, C. Buerger, C. Joukhadar, S. Kljucar, and C. Kloft Does linezolid inhibit its own metabolism? Population pharmacokinetics as a tool to explain the observed nonlinearity in both healthy volunteers and septic patients Drug Metab Dispos 35 2007 1816 1823
13. Y. Hiraki, Y. Tsuji, M. Hiraike, N. Misumi, K. Matsumoto, and K. Morita Correlation between serum linezolid concentration and the development of thrombocytopenia Scand J Infect Dis 44 2012 60 64
14. A. Di Paolo, P. Malacarne, E. Guidotti, R. Danesi, and M. Del Tacca Pharmacological issues of linezolid: an updated critical review Clin Pharmacokinet 49 2010 439 447
15. S. Swoboda, M.C. Ober, C. Lichtenstern, S. Saleh, V. Schwenger, and H.G. Sonntag Pharmacokinetics of linezolid in septic patients with and without extended dialysis Eur J Clin Pharmacol 66 2010 291 298